R-Tech Ueno begins phase I trial to test RL-023's safety as therapy for eyelash hypotrichosis Feb. 9, 2011
Etanercept demonstrates little activity to date in phase II trial in discoid lupus erythematosus Feb. 9, 2011
RSS